Literature DB >> 29884733

Transformation in Immunosuppression: Are We Ready for it?

Amtul Aala1, Daniel C Brennan2.   

Abstract

Keywords:  randomized controlled trials; tacrolimus; transplantation

Mesh：

Substances：

Year:  2018        PMID： 29884733      PMCID： PMC6050924          DOI： 10.1681/ASN.2018050491

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  12 in total

1.  Reduced exposure to calcineurin inhibitors in renal transplantation.

Authors:  Henrik Ekberg; Helio Tedesco-Silva; Alper Demirbas; Stefan Vítko; Björn Nashan; Alp Gürkan; Raimund Margreiter; Christian Hugo; Josep M Grinyó; Ulrich Frei; Yves Vanrenterghem; Pierre Daloze; Philip F Halloran
Journal:  N Engl J Med       Date:  2007-12-20       Impact factor: 91.245

2.  Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients.

Authors:  Philip F Halloran; Jessica Chang; Konrad Famulski; Luis G Hidalgo; Israel D R Salazar; Maribel Merino Lopez; Arthur Matas; Michael Picton; Declan de Freitas; Jonathan Bromberg; Daniel Serón; Joana Sellarés; Gunilla Einecke; Jeff Reeve
Journal:  J Am Soc Nephrol       Date:  2014-11-06       Impact factor: 10.121

3.  Banff Borderline Changes Suspicious for Acute T Cell-Mediated Rejection: Where Do We Stand?

Authors:  J U Becker; A Chang; V Nickeleit; P Randhawa; C Roufosse
Journal:  Am J Transplant       Date:  2016-05-05       Impact factor: 8.086

4.  Hyalinosis Lesions in Renal Transplant Biopsies: Time-Dependent Complexity of Interpretation.

Authors:  G Einecke; J Reeve; P F Halloran
Journal:  Am J Transplant       Date:  2017-01-03       Impact factor: 8.086

5.  OPTN/SRTR 2016 Annual Data Report: Kidney.

Authors:  A Hart; J M Smith; M A Skeans; S K Gustafson; A R Wilk; A Robinson; J L Wainright; C R Haynes; J J Snyder; B L Kasiske; A K Israni
Journal:  Am J Transplant       Date:  2018-01       Impact factor: 8.086

6.  Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.

Authors:  Brian J Nankivell; Chow H PʼNg; Philip J OʼConnell; Jeremy R Chapman
Journal:  Transplantation       Date:  2016-08       Impact factor: 4.939

7.  Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure.

Authors:  G Einecke; B Sis; J Reeve; M Mengel; P M Campbell; L G Hidalgo; B Kaplan; P F Halloran
Journal:  Am J Transplant       Date:  2009-11       Impact factor: 8.086

8.  Sirolimus and secondary skin-cancer prevention in kidney transplantation.

Authors:  Sylvie Euvrard; Emmanuel Morelon; Lionel Rostaing; Eric Goffin; Anabelle Brocard; Isabelle Tromme; Nilufer Broeders; Veronique del Marmol; Valérie Chatelet; Anne Dompmartin; Michèle Kessler; Andreas L Serra; Günther F L Hofbauer; Claire Pouteil-Noble; Josep M Campistol; Jean Kanitakis; Adeline S Roux; Evelyne Decullier; Jacques Dantal
Journal:  N Engl J Med       Date:  2012-07-26       Impact factor: 91.245

9.  Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis.

Authors:  Elizabeth L Yanik; Kulsoom Siddiqui; Eric A Engels
Journal:  Cancer Med       Date:  2015-06-24       Impact factor: 4.452

10.  Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus.

Authors:  F Shihab; Y Qazi; S Mulgaonkar; K McCague; D Patel; V R Peddi; D Shaffer
Journal:  Am J Transplant       Date:  2017-03-04       Impact factor: 8.086
View more
  1 in total

Review 1.  Innovative immunosuppression in kidney transplantation: A challenge for unmet needs.

Authors:  Maurizio Salvadori; Aris Tsalouchos
Journal:  World J Transplant       Date:  2022-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.